Company Info
Phone(224) 383-3000
Year Established
2005
Ticker
AMGN
Exchange
NASDAQ
Contacts
Tim WalbertChair, President & CEO
Andy Pasternak
Chief Strategy Officer
Elizabeth H.Z. Thompson, Ph.D.
Executive VP, R&D
Jane Gonnerman
Senior VP, Corporate Development
Jeffrey W. Sherman, M.D., FACP
CMO
Michael DesJardin
Executive VP, Technical Operations
Aaron Cox
CFO
Sean Clayton
General Counsel
Keli Walbert
Executive VP, U.S. Operations
Company Description
Horizon Therapeutics, an Amgen company, is a biopharmaceutical company focused on researching, developing and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases.
